Rchr
J-GLOBAL ID:200901052191207180   Update date: Sep. 04, 2024

Fujimura Taku

フジムラ タク | Fujimura Taku
Affiliation and department:
Job title: Assistant Professor
Homepage URL  (1): http://www.derma.med.tohoku.ac.jp/
Research field  (1): Dermatology
Research keywords  (3): melanoma ,  Oncoimmunology ,  Dermatology
Research theme for competitive and other funds  (18):
  • 2023 - 2026 Development of novel assist tool for the diagnosis of skin cancer by the active measurement of effective thermal conductivity
  • 2021 - 2025 線溶系制御因子を標的とした新規複合的がん免疫療法の確立
  • 2021 - 2024 Investigation for the roles of IL-17/LL37 signaling in melanoma
  • 2021 - 2024 Anti-PD-1 plus TM5614 immunotherapy for unresectable malignant melanoma: Protocol for an investigator-initiated, open-label, single-arm, multicentre, phase 2 clinical trial
  • 2020 - 2023 能動的精密表面温度計測を用いた熱パルスレーダ-による癌の生体内診断
Show all
Papers (288):
  • Emi Yamazaki, Taku Fujimura, Manami Takahashi-Watanabe, Satsuki Tada, Chisako Kitayama, Ryo Amagai, Yumi Kambayashi, Masahiro Watanabe, Masamitsu Maekawa, Nariyasu Mano, et al. Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial. The British journal of dermatology. 2024
  • Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoru Mizuhashi, Takamichi Ito, Takeo Maekawa, Shoichiro Ishizuki, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, et al. Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes. Cancers. 2024. 16. 15
  • Yoji Hirai, Jun Sakurai, Shiho Yoshida, Takashi Kikuchi, Toshiharu Mitsuhashi, Tomoko Miyake, Taku Fujimura, Riichiro Abe, Hiroki Fujikawa, Hikari Boki, et al. Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma. The Journal of dermatology. 2024
  • Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, et al. Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study. Endocrine journal. 2024
  • Taku Fujimura, Koji Yoshino, Hiroshi Kato, Satoshi Fukushima, Shoichiro Ishizuki, Atsushi Otsuka, Shigeto Matsushita, Ryo Amagai, Yusuke Muto, Emi Yamazaki, et al. Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial. The British journal of dermatology. 2024
more...
MISC (137):
Patents (2):
Books (2):
  • Immunology of the skin
    Springer 2016
  • 皮膚科臨床アセット ここまでわかった乾癬の病態と治療
    中山書店 2012
Lectures and oral presentations  (36):
  • Generation of B7H1-expressing CD11b+Gr1+ myeloid derived suppressor cells (MDSCs) during immune-modulatory therapy for B16F10 melanoma.
    (第37回日本研究皮膚科学会 2012)
  • Comparison of immunosuppressive cells and immunomodulatory cells in Angiosarcoma; the possible novel supportive therapies for angiosarcoma.
    (第37回日本研究皮膚科学会 2012)
  • Comparison of Foxp3+ regulatory T-cells and CD163+ macrophages in invasive and non-invasive extramammary Paget’s disease.
    (第37回日本研究皮膚科学会 2012)
  • 生涯、襁褓を着用してきた中年女性の外陰部に生じていた多発性表皮膿腫
    (第360回日本皮膚科学会宮城地方会 2012)
  • Imiquimod augments the expression of B7H1 on CD11b+Gr1+ myeloid derived suppressor cells (MDSCs) in B16F10 melanoma
    (European Society for Dermatological Research 2012)
more...
Education (2):
  • - 2004 Tohoku University Graduate School, Division of Medicine
  • - 1998 Tohoku University Faculty of Medicine
Professional career (1):
  • 医学博士 (Tohoku University)
Work history (7):
  • 2023/04 - 現在 Tohoku University Department of Dermatology Associate professor
  • 2017/09 - 2023/03 東北大学病院 皮膚科 講師
  • 2010/08 - 2017/08 東北大学医学系研究科皮膚科学分野 助教
  • 2007/07 - 2010/07 Department of Dermatology, University of Heidelberg Research Fellow
  • 2004/04 - 2007/06 東北大学医学部付属病院 病院助手 助手
Show all
Committee career (2):
  • 2018/09 - 現在 日本皮膚科学会 皮膚リンパ腫治療安全検討ワーキンググループ
  • 2017/04 - 現在 日本皮膚科学会 皮膚悪性腫瘍ガイドライン委員
Awards (4):
  • 2018/04 - 日本臨床皮膚科学会 ポスター賞 銀賞
  • 2016/05 - Japan Skin Cancer Society Japan Skin Cancer Society Award Immunomodulatory effect of peritumoral administration of interferon-beta on melanoma through tumor-associated macrophages.
  • 2011/05/24 - 国際皮膚科学会 22nd WCD2011, ILDS Scholarship
  • 2006/06/03 - 日本皮膚科学会 第105回日本皮膚科学会総会優秀ポスター賞
Association Membership(s) (6):
Society of Investigative Dermatology(2006/05-2019/10) ,  日本研究皮膚科学会(2004/03-2019/10) ,  日本免疫学会(2000/11-2019/10) ,  日本癌学会(2000/09-2006/09) ,  日本皮膚科学会(1998/07-2019/10) ,  日本皮膚悪性腫瘍学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page